https://www.pharmaceutical-technology.com/data-insights/df-6002-dragonfly-therapeutics-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/
DF-6002 is under clinical development by Dragonfly Therapeutics and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma).
transitional cell carcinomadfdragonflytherapeuticsurothelial
https://uroweb.org/guidelines/upper-urinary-tract-urothelial-cell-carcinoma/chapter/disease-management
The European Association of Urology (EAU) NMIBC Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information...
upper urinary tracturothelial cell carcinomaeauguidelinesdisease